 Michael Yeager
Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 22 | 2021 | 1737 | 2.450 |
Why?
| | Down Syndrome | 5 | 2023 | 338 | 1.650 |
Why?
| | Pulmonary Artery | 7 | 2021 | 1028 | 0.850 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 2 | 2021 | 16 | 0.780 |
Why?
| | Matrix Metalloproteinases | 2 | 2021 | 89 | 0.770 |
Why?
| | Ventricular Function | 1 | 2021 | 56 | 0.750 |
Why?
| | Respiratory Tract Infections | 1 | 2023 | 321 | 0.670 |
Why?
| | Fibroblasts | 6 | 2013 | 839 | 0.600 |
Why?
| | Vascular Stiffness | 1 | 2021 | 408 | 0.540 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2017 | 58 | 0.530 |
Why?
| | Blood Vessels | 2 | 2013 | 180 | 0.490 |
Why?
| | Biomarkers | 2 | 2015 | 3418 | 0.490 |
Why?
| | Lymphoid Tissue | 1 | 2013 | 62 | 0.440 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2012 | 417 | 0.420 |
Why?
| | Lung | 6 | 2023 | 3593 | 0.410 |
Why?
| | Proteomics | 2 | 2015 | 844 | 0.390 |
Why?
| | Unfolded Protein Response | 1 | 2012 | 43 | 0.390 |
Why?
| | Arteritis | 1 | 2012 | 27 | 0.390 |
Why?
| | Proteome | 1 | 2015 | 339 | 0.380 |
Why?
| | Precision Medicine | 1 | 2015 | 339 | 0.380 |
Why?
| | Microsatellite Repeats | 2 | 2002 | 136 | 0.370 |
Why?
| | Mesoderm | 2 | 2011 | 138 | 0.370 |
Why?
| | Phagocytes | 1 | 2011 | 90 | 0.360 |
Why?
| | Lung Diseases | 1 | 2017 | 703 | 0.360 |
Why?
| | Myeloid Cells | 1 | 2011 | 128 | 0.360 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 2 | 2002 | 213 | 0.350 |
Why?
| | Endothelin-1 | 1 | 2012 | 167 | 0.350 |
Why?
| | Blood Proteins | 1 | 2012 | 233 | 0.350 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2012 | 236 | 0.340 |
Why?
| | Immunoglobulin G | 1 | 2013 | 776 | 0.340 |
Why?
| | Endothelium, Vascular | 3 | 2002 | 848 | 0.280 |
Why?
| | Autoantibodies | 1 | 2013 | 1354 | 0.260 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 1729 | 0.250 |
Why?
| | Receptors, Transforming Growth Factor beta | 2 | 2002 | 52 | 0.230 |
Why?
| | Cytokines | 4 | 2017 | 1843 | 0.230 |
Why?
| | Biology | 1 | 2023 | 78 | 0.210 |
Why?
| | Disease Models, Animal | 4 | 2023 | 3549 | 0.200 |
Why?
| | Flow Cytometry | 4 | 2019 | 1087 | 0.200 |
Why?
| | Histone Deacetylase Inhibitors | 2 | 2013 | 198 | 0.190 |
Why?
| | DNA-Binding Proteins | 2 | 2012 | 1317 | 0.180 |
Why?
| | Proto-Oncogene Proteins | 2 | 2002 | 611 | 0.180 |
Why?
| | Arterial Pressure | 1 | 2021 | 99 | 0.180 |
Why?
| | Male | 14 | 2023 | 55663 | 0.180 |
Why?
| | Child | 6 | 2021 | 18366 | 0.180 |
Why?
| | Humans | 23 | 2023 | 114937 | 0.180 |
Why?
| | Prognosis | 2 | 2017 | 3344 | 0.160 |
Why?
| | Rats | 5 | 2013 | 4963 | 0.160 |
Why?
| | Interferon-alpha | 1 | 2019 | 187 | 0.150 |
Why?
| | MicroRNAs | 2 | 2015 | 601 | 0.150 |
Why?
| | Animals | 13 | 2023 | 31839 | 0.150 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 63 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2017 | 3008 | 0.140 |
Why?
| | Female | 11 | 2023 | 59581 | 0.140 |
Why?
| | TRPM Cation Channels | 1 | 2017 | 67 | 0.140 |
Why?
| | Adolescent | 4 | 2021 | 17829 | 0.140 |
Why?
| | Hemodynamics | 1 | 2021 | 1014 | 0.140 |
Why?
| | Histone Deacetylases | 3 | 2013 | 196 | 0.130 |
Why?
| | Gene Expression Profiling | 3 | 2013 | 1523 | 0.130 |
Why?
| | Blood Flow Velocity | 1 | 2017 | 387 | 0.130 |
Why?
| | Mutation | 4 | 2003 | 3354 | 0.130 |
Why?
| | Inflammation | 4 | 2017 | 2485 | 0.130 |
Why?
| | Rats, Wistar | 2 | 2013 | 368 | 0.130 |
Why?
| | Magnetic Resonance Angiography | 1 | 2017 | 221 | 0.130 |
Why?
| | Ventricular Function, Right | 1 | 2017 | 252 | 0.130 |
Why?
| | Cell Proliferation | 2 | 2013 | 2199 | 0.130 |
Why?
| | Cardiovascular System | 1 | 2017 | 126 | 0.130 |
Why?
| | Atrial Natriuretic Factor | 1 | 2015 | 57 | 0.120 |
Why?
| | Breath Tests | 1 | 2015 | 82 | 0.120 |
Why?
| | Heart Ventricles | 2 | 2017 | 711 | 0.120 |
Why?
| | Cause of Death | 1 | 2017 | 363 | 0.120 |
Why?
| | Chemokine CCL2 | 2 | 2013 | 105 | 0.120 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2015 | 96 | 0.120 |
Why?
| | Phenotype | 4 | 2017 | 2817 | 0.120 |
Why?
| | Cell-Derived Microparticles | 1 | 2015 | 58 | 0.120 |
Why?
| | Fluorescent Antibody Technique | 2 | 2011 | 396 | 0.110 |
Why?
| | Mice | 6 | 2023 | 14936 | 0.110 |
Why?
| | Vascular Remodeling | 1 | 2015 | 153 | 0.110 |
Why?
| | Hypoxia | 4 | 2013 | 960 | 0.110 |
Why?
| | Angiotensin II | 1 | 2013 | 90 | 0.110 |
Why?
| | Receptors, Growth Factor | 2 | 2003 | 49 | 0.110 |
Why?
| | Adventitia | 1 | 2012 | 37 | 0.100 |
Why?
| | Cardiac Catheterization | 2 | 2017 | 535 | 0.100 |
Why?
| | Echocardiography | 1 | 2015 | 555 | 0.100 |
Why?
| | Metalloporphyrins | 1 | 2013 | 104 | 0.100 |
Why?
| | Polymerase Chain Reaction | 2 | 2013 | 995 | 0.100 |
Why?
| | Regulatory Factor X Transcription Factors | 1 | 2012 | 9 | 0.100 |
Why?
| | Cell Movement | 2 | 2013 | 867 | 0.100 |
Why?
| | Bronchi | 1 | 2013 | 243 | 0.100 |
Why?
| | Activating Transcription Factor 6 | 1 | 2012 | 16 | 0.100 |
Why?
| | Endothelin A Receptor Antagonists | 1 | 2012 | 24 | 0.100 |
Why?
| | Monocytes | 2 | 2012 | 504 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 797 | 0.100 |
Why?
| | Receptor, Endothelin B | 1 | 2012 | 51 | 0.100 |
Why?
| | Receptor, Endothelin A | 1 | 2012 | 59 | 0.100 |
Why?
| | Inflammasomes | 1 | 2013 | 115 | 0.100 |
Why?
| | bcl-2-Associated X Protein | 2 | 2002 | 45 | 0.100 |
Why?
| | Fibrosis | 1 | 2013 | 454 | 0.100 |
Why?
| | Leukocyte Common Antigens | 1 | 2011 | 76 | 0.090 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 146 | 0.090 |
Why?
| | Chemokine CXCL12 | 1 | 2011 | 74 | 0.090 |
Why?
| | Peptide Fragments | 1 | 2015 | 668 | 0.090 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 164 | 0.090 |
Why?
| | Cell Count | 1 | 2011 | 305 | 0.090 |
Why?
| | Immunomodulation | 1 | 2011 | 84 | 0.090 |
Why?
| | Transforming Growth Factor beta | 2 | 2004 | 449 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2013 | 476 | 0.090 |
Why?
| | Dendritic Cells | 1 | 2013 | 436 | 0.090 |
Why?
| | Heart Defects, Congenital | 1 | 2017 | 665 | 0.090 |
Why?
| | Stem Cells | 2 | 2012 | 546 | 0.090 |
Why?
| | Vasodilator Agents | 1 | 2012 | 305 | 0.090 |
Why?
| | Cell Separation | 1 | 2011 | 292 | 0.090 |
Why?
| | Hyaluronic Acid | 1 | 2012 | 189 | 0.090 |
Why?
| | Endothelial Cells | 1 | 2015 | 685 | 0.090 |
Why?
| | Ventricular Remodeling | 1 | 2012 | 227 | 0.090 |
Why?
| | Arrhythmias, Cardiac | 1 | 2011 | 279 | 0.080 |
Why?
| | Infant | 2 | 2012 | 7937 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2013 | 696 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2102 | 0.080 |
Why?
| | Child, Preschool | 2 | 2012 | 9086 | 0.080 |
Why?
| | Signal Transduction | 3 | 2013 | 4525 | 0.070 |
Why?
| | Autoimmunity | 1 | 2013 | 818 | 0.070 |
Why?
| | Phosphorylation | 1 | 2012 | 1572 | 0.070 |
Why?
| | Epigenesis, Genetic | 1 | 2011 | 523 | 0.070 |
Why?
| | Young Adult | 2 | 2011 | 10478 | 0.070 |
Why?
| | Pneumonia | 1 | 2011 | 568 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 2326 | 0.060 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2005 | 13 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3053 | 0.060 |
Why?
| | Angiopoietins | 1 | 2003 | 13 | 0.060 |
Why?
| | Transcription Factors | 1 | 2012 | 1530 | 0.060 |
Why?
| | Receptors, Serotonin | 1 | 2003 | 32 | 0.060 |
Why?
| | Risk Factors | 1 | 2017 | 8637 | 0.060 |
Why?
| | Herpesvirus 8, Human | 1 | 2003 | 61 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2002 | 744 | 0.050 |
Why?
| | Base Pair Mismatch | 1 | 2002 | 14 | 0.050 |
Why?
| | MutS Homolog 2 Protein | 1 | 2002 | 12 | 0.050 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 50 | 0.050 |
Why?
| | Herpesviridae Infections | 1 | 2003 | 138 | 0.050 |
Why?
| | Frameshift Mutation | 1 | 2002 | 27 | 0.050 |
Why?
| | Lymphokines | 1 | 2002 | 111 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2005 | 752 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2017 | 4719 | 0.050 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2002 | 227 | 0.040 |
Why?
| | Cattle | 2 | 2013 | 924 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2001 | 372 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2001 | 855 | 0.040 |
Why?
| | Cell Division | 1 | 2001 | 759 | 0.040 |
Why?
| | Adult | 4 | 2019 | 30608 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2012 | 9105 | 0.040 |
Why?
| | Listeriosis | 1 | 2017 | 61 | 0.040 |
Why?
| | Base Sequence | 1 | 2001 | 2118 | 0.040 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2017 | 174 | 0.030 |
Why?
| | Listeria monocytogenes | 1 | 2017 | 111 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 929 | 0.030 |
Why?
| | Blotting, Western | 2 | 2011 | 1151 | 0.030 |
Why?
| | Apoptosis | 2 | 2002 | 2371 | 0.030 |
Why?
| | Cell Line | 1 | 2001 | 2640 | 0.030 |
Why?
| | Macrophages | 2 | 2012 | 1266 | 0.030 |
Why?
| | Stroke Volume | 1 | 2017 | 510 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 536 | 0.030 |
Why?
| | DNA | 1 | 2001 | 1351 | 0.030 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2013 | 14 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 69 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2017 | 686 | 0.030 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 61 | 0.030 |
Why?
| | Immunoblotting | 1 | 2013 | 283 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 107 | 0.030 |
Why?
| | 3' Untranslated Regions | 1 | 2013 | 129 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 190 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 171 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2013 | 339 | 0.030 |
Why?
| | Vasa Vasorum | 1 | 2012 | 33 | 0.030 |
Why?
| | Caspase 1 | 1 | 2013 | 140 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2017 | 725 | 0.020 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2013 | 144 | 0.020 |
Why?
| | Connective Tissue | 1 | 2011 | 36 | 0.020 |
Why?
| | Interleukin-18 | 1 | 2013 | 219 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 2587 | 0.020 |
Why?
| | Benzamides | 1 | 2012 | 169 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 305 | 0.020 |
Why?
| | Cell Cycle | 1 | 2013 | 544 | 0.020 |
Why?
| | Middle Aged | 3 | 2019 | 26806 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2013 | 370 | 0.020 |
Why?
| | Macrophage Activation | 1 | 2011 | 164 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2012 | 424 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2011 | 430 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2012 | 378 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2011 | 777 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4427 | 0.020 |
Why?
| | Pyrimidines | 1 | 2012 | 378 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 425 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 1897 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1422 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2013 | 1317 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2211 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 1699 | 0.020 |
Why?
| | Prospective Studies | 1 | 2017 | 6218 | 0.020 |
Why?
| | Densitometry | 1 | 2005 | 29 | 0.020 |
Why?
| | Blood Pressure | 1 | 2012 | 1537 | 0.020 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 24 | 0.020 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2005 | 57 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 2005 | 195 | 0.020 |
Why?
| | Epithelium | 1 | 2005 | 298 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2012 | 3897 | 0.010 |
Why?
| | Bone Morphogenetic Protein Receptors | 1 | 2003 | 4 | 0.010 |
Why?
| | Species Specificity | 1 | 2005 | 547 | 0.010 |
Why?
| | Genes, Viral | 1 | 2003 | 89 | 0.010 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2003 | 48 | 0.010 |
Why?
| | Cyclins | 1 | 2003 | 78 | 0.010 |
Why?
| | Down-Regulation | 1 | 2005 | 596 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2005 | 797 | 0.010 |
Why?
| | Arteries | 1 | 2004 | 247 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 61 | 0.010 |
Why?
| | Up-Regulation | 1 | 2005 | 812 | 0.010 |
Why?
| | Hypertrophy | 1 | 2002 | 111 | 0.010 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 103 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 2005 | 436 | 0.010 |
Why?
| | DNA, Viral | 1 | 2003 | 350 | 0.010 |
Why?
| | Viral Proteins | 1 | 2003 | 281 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2003 | 729 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2002 | 499 | 0.010 |
Why?
| | RNA | 1 | 2001 | 810 | 0.010 |
Why?
|
|
Yeager's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|